Adult Respiratory Vaccination Delivers Up to $12 in Societal Value for Every $1 Spent, Analysis Finds
Benefit-cost modeling estimated $22B annual spend produces $101B-$241B net benefits, preventing ~18,500 deaths and 300,000 hospitalizations in a single year.
Effectiveness of nirsevimab immunisation on invasive pneumococcal disease in children nationwide in France: an observational cohort study
These findings suggest an additional benefit of nirsevimab implementation beyond RSV disease prevention, but further studies are needed.
Article
Scientific Papers
Viral pneumonia in older adults: from immunosenescence and chronic disease to vaccine-modifiable risk
This narrative review examines viral pneumonia in older adults at the intersection of immunosenescence, frailty, multimorbidity and immune compromise.
#EURespiDay 2026 looks ahead to a Council Recommendation on respiratory virus immunisation for cardiovascular prevention
Organised by the Steering Group on Prevention of Respiratory Infections
Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season - COVID-19, RSV, Influenza
JAMA Special Communications - Three systematic reviews identify & summarise recent reporting on the effectiveness and safety of vaccines and influenza/RSV/Covid-19 epidemiology in the US.
WHO prequalifies multi-dose RSV vaccine vial, paving the way to protecting more infants globally
The WHO has prequalified the multi-dose vial presentation of the maternal respiratory syncytial virus (RSV) vaccine, RSVpreF (ABRYSVO®).
News
Reports
Partner Organisations
EHMA: Prepact - A Receptivity Assessment for HMPV and RSV Diagnosis in Older Adults
EMA White Paper assessing receptivity to improving testing and surveillance for RSV & HMPV across Europe, with a specific focus on older adults.
Article
News
In the media
Policy & Recommendations
#IDCBreathAndBeyond calls for respiratory virus prevention to be fully integrated into NCD care
Campaign led by the ESWI IDC, calling for better prevention, better care, better protection for people living with chronic diseases